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The binding of a series of small organic molecules, acting as agonists of the cannabinoid receptor 
CB1, was investigated by means of three methods of computational chemistry. Binding modes were 
predicted by means of molecular docking, and binding free energy was estimated via docking, 
molecular-mechanics Poisson-Boltzmann surface area method, and multistate Bennett acceptance 
ratio. No evident correlation was observed for the molecules between the experimental 
characteristics of affinity and three computed binding free energy estimates. The reasons for the 
discrepancy were discussed. 
________________________________________________________________________________ 
Introduction 
The endocannabinoid system (ECS) is a 
perspective therapeutic target, which 
participates in multiple physiological processes, 
such as appetite stimulation, immune response, 
vomiting control, pain modulation [1-3], and 
also in pathological conditions, for example 
Huntington’s disease and stroke [4, 5]. 
CB1 and CB2 receptors constitute most 
recognized part of ECS. Their natural agonists, 
so-called endocannabinoids, are anandamide 
and 2-arachidonoylglyerol. Another well-known 
partial agonist is Δ9-tetrahydrocannabinol 
(THC), the natural component of plant 
Cannabis sativa, which is used for centuries for 
its recreational and medicinal properties [1, 6]. 
In last decades new potent agonists of 
CB1 and CB2 receptors were synthesized. While 
initially they were developed with legitimate 
research purposes, synthetic cannabinoids 
started new era of “designer drugs”, semi-legal 
replacements of regulated psychoactive 
compounds. While most of these synthetic 
cannabinoids are already known to scientific 
community, their structural diversity presents 
unlimited possibilities for further modification, 
thus evading state regulation [7, 8]. 
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Fast development of synthetic 
cannabinoids poses significant treat for public 
health. They have low binding affinity and are 
not subject to any clinical tests, so overdosing is 
frequent, with typical symptoms including 
anxiety and panic attacks [9, 10]. 
Earlier studies had to use QSAR to 
predict affinity of synthetic cannabinoids [11].   
But recent publication of high precision CB1 
[12,13] and CB2 [14] crystal structures allows 
to estimate and explain binding affinity using 
more reliable methods of molecular docking 
[15] and molecular dynamics [16,17]. 
We expect that comparison of computed 
binding affinity of known agonists will allow to 
develop high-quality agonist pharmacophore 
models. This, along with purely 
pharmacological applications, will make robust 
identification and classification of narcotic 
drugs with THC-like action, and pave the path 
for estimation of their health risks. 
Experimental part 
Computational Methods 
We chose three principally different 
approaches to estimate binding free energies of 
ligands to CB1. The first one is the common 
method of molecular docking, and the others are 
based on molecular dynamics (MD) simulation. 
The second one is Molecular Mechanics 
Poisson-Boltzmann Surface Area (MMPBSA) 
[18] approach. It is but approximate but 
computationally cheap and parameterized 
specifically for protein-ligand systems. The 
third method is multistate Bennett acceptance 
ratio (MBAR) from the family of alchemical 
transformation approaches [19,20]. It is a 
rigorous method of universal applicability but is 
costly because requires longer equilibration and 
several additional simulations to be performed. 
Protein preparation for docking. The 
initial structure of CB1 protein in active apo- 
conformation was taken from the paper [17]. 
There, it was reconstructed from the crystal 
structure available in Protein Data Bank (ID: 
5XRA [12]). Namely, the missing and mutated 
parts were restored, and equilibration via 
molecular dynamics in physiological conditions 
(immersed into lipid bilayer solvated in 0.15 M 
NaCl solution) was performed. 
The final structure of the intact active 
conformation of CB1 protein for docking was 
prepared using the Structure Preparation module 
of the Molecular Operating Environment 
(MOE) software [21]. The protonation and 
tautomeric states of Arg, Asp, Glu, His and Lys 
residues were adjusted to match pH = 7.0 using 
the Protonate 3D module. Restrained 
minimization with the AMBER forcefield was 
performed via the Energy Minimize panel. 
Ligand preparation for docking. Well-
known cannabinoid receptor CB1 agonists were 
selected for our study (Figure 1): widely 
studied THC, three N-pentylindole derivatives 
(JWH-018, UR-144, PB-22) and their 
monofluorinated derivatives (AM-2201, XLR-
11, 5F-PB-22, respectively). All these ligands 
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have Ki values <50 nM according to the 
ChEMBL database. 
 
 
Figure 1. Agonist structures selected for investigation. 
 
All ligand structures (Figure 1) for Δ9-
tetrahydrocannabinol (THC), naphthalen-1-yl(1-
pentyl-1H-indol-3-yl)methanone (JWH-018), 
(1-(5-fluoropentyl)-1H-indol-3-yl)(naphthalen-
1-yl)methanone (AM-2201), (1-pentyl-1H-
indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone (UR-144), 
(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone (XLR-11), 
quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate 
(PB-22) and quinolin-8-yl 1-(5-fluoropentyl)-
1H-indole-3-carboxylate (5F-PB-22) were 
initially drawn using the ChemDraw 
Professional and prepared using the LigX 
module of MOE. LigX generated stereoisomers 
and tautomers within a pH range of 7.0 ± 2.0. 
For each ligand, the lowest energy conformer 
was retained. Next, the ligands were optimized 
via energy minimization using the 
“AMBER10:EHT” forcefield while allowing 
adjustment to H atoms. The RMSD gradient 
value was kept at 0.1 kcal/mol·A2 (energy 
minimization is terminated when RMSD 
gradient falls below this value). The calculated 
electrostatic potential charges were used as 
partial charges of ligand atoms. 
Molecular docking. The ligands were 
docked to the orthosteric binding site of the 
active conformation of the CB1 structure by 
using the Dock panel of MOE software. We 
decided to dock the selected ligands only for 
active conformation of the CB1 receptor, since, 
according to Jung et al [17], agonists more 
favorably interacted with the active form and 
had lower binding energies to the inactive one.  
The induced-fit docking (IFD) protocol 
was used in all cases. The receptor was kept at 
“Receptor Atoms” while receptor site was 
chosen to be “Selected atoms”. No “wall 
constraints” were used. All docking jobs were 
performed with the placement method “Triangle 
Matcher” with post placement refinement kept 
as “Forcefield”. The initial scoring function was 
kept as “London dG”, and “GBVI/WSA dG” 
was used as the final scoring function [22]. The 
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pose with the lowest docking score (S-score) 
was retained for each ligand. 
MD simulations setup 
The initial structures of CB1 protein in 
active apo- conformation and in active 
conformation with bound THC were taken from 
the original paper [17]. They consist of the 
protein embedded to a 1-palmitoyl-2-
oleoylphophatidylcholine (POPC) bilayer 
surrounded by 0.15 M NaCl solution, and are 
equilibrated via MD run without (apo- 
conformation) or with THC inside. 
Here, as initial configurations for MD, 
the same structure was employed with a ligand 
placed inside the protein in a pose predicted by 
molecular docking (Figure 2). At the same 
time, four water molecules initially found inside 
the empty apo- protein were removed. In the 
case of THC, we used the original structure 
from [17] without modifications. 
The distribution of protonation states in 
the initial structure was preserved; it matches 
pH = 7.0. Particularly, His residues are neutral, 
with H atom bonded to Nδ (acronym "HSD"). 
We employed two forcefields for the 
computations. Firstly, following the original 
study [17], CHARMM36 and CGenFF 
forcefields [23,24] were used in order to keep 
compatibility. Potential model for POPC is 
already present in it, while the ones for ligands 
were prepared using ParamChem web server. 
As usual for CHARMM, water was described 
with TIP3P model. 
 
 
Figure 2. Initial configuration for MD simulations with 
CB1 in apo- conformation. Phophatidylcholine groups are 
colored orange, while the rest of POPC molecules is 
colored brown. Water, NaCl, and ligand are not shown. 
 
The second one was OPLS-AA/M 
forcefield [25] that is a recent update of a well-
known and validated OPLS-AA forcefield, 
containing improved parameters for peptide 
dihedral angles. For POPC, a compatible 
modern potential model was taken from [26, 
27]. It is developed in the framework of OPLS-
AA, but contains some changes in parameters 
describing dihedral angles allowing it to 
reproduce the properties of POPC bilayers well. 
For ligands, the potential models were prepared 
with the help of LigParGen server, which is 
tailored for the OPLS-AA/M forcefield [28]. 
Because all the ligands were neutral molecules, 
the atomic point charges were computed using 
1.14*CM1A model with LBCC correction. 
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Finally, water model was TIP3P because POPC 
was parameterized together with it [27]. 
Molecular dynamics simulations was 
carried out using GROMACS 5 software. For 
CHARMM36 runs, we reproduced the settings 
from [17]. Namely, temperature 310 K and 
pressure 1 bar were maintained by means of 
Nose-Hoover thermostat and Parrinello-Rahman 
barostat with semiisotropic coupling, 
respectively; time constants equaled 1 ps. The 
parameters were as follows: time step 2 fs, 3D 
periodic boundary conditions, constraints on all 
bonds involving hydrogen atoms, PME method 
for computing electrostatics with real space 
cutoff 1.2 nm, cutoff of van der Waals 
interactions at 1.2 nm with force-switch at 1 nm. 
The duration of a run was 5 ns for each ligand. 
For OPLS-AA/M runs, some settings 
were changed: thermostat time constant was 0.4 
ps, constraints on all bonds, PME real space 
cutoff 1 nm, plain cutoff of van der Waals 
interactions at 1 nm. The same and settings were 
employed during parameterizing POPC [27]. 
Simulations ran for 10 ns because additional 
equilibration of the initial configurations 
(originally made in CHARMM36 forcefield) 
was needed. 
The MMPBSA computations were 
performed using g_mmpbsa program [29,30]. 
Polar interactions were treated by non-linearized 
version of Poisson-Boltzmann equation for 
higher accuracy, apolar ones were calculated 
basing on solvent-accessible surface areas, the 
rest of settings were set at default values (in 
particular, eco = 80, pdie = 2, srad = 1.4). For 
processing, protein-ligand complex 
configurations were extracted each 20 ps from 
the last 5 ns (OPLS-AA/M) or 3 ns 
(CHARMM36) of MD trajectories. 
Because MBAR method requires 
simulating a single system at several values of 
coupling parameter λ, two series of additional 
simulations were carried out for each ligand. 
Firstly, each ligand was simulated in CB1 at 
each λ value for 6 ns starting from the final 
configuration of its ordinary MD run. The first 3 
ns were discarded as equilibration and were not 
used for calculations. Secondly, each ligand was 
solvated in a water box with size 6.5 nm and 
then simulated at each λ value for 3 ns; the first 
1 ns was omitted. The following λ schedules 
were used: {0.0;  0.2;  0.4;  0.6;  0.8;  1.0;  1.0} 
for electrostatic interactions and {0.0;  0.2;  0.4;  
0.6;  0.8;  0.9;  1.0} for van der Waals 
interactions, where λ values 0.0 and 1.0 
correspond to the specified interactions between 
ligand and environment turned on and off, 
respectively. The difference between schedules 
ensures the electrostatic interactions are 
disabled before the van der Waals ones are that 
is required to avoid singularities. For the last 3 λ 
values, stochastic dynamics integrator was used, 
as is recommended for proper sampling.  
Results and discussion 
 Docking results 
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All agonist ligands studied were docked 
to the CB1 active conformation by molecular 
docking to predict the ligand binding pose at the 
orthosteric binding site. The docking results for 
some agonists, namely XLR-11, PB-22 and 5F-
PB-22 are shown in Figures 3-5, respectively. 
All ligands were well fixed in the active 
conformation of the receptor and showed 
similar binding poses at the orthosteric binding 
site. 
 
Figure 3. Binding pose of XLR-11 in CB1 active 
conformation. 
 
Figure 4. Binding pose of PB-22 in CB1 active 
conformation. 
 
 
Figure 5. Binding pose of 5F-PB-22 in CB1 active 
conformation. 
The main interactions between the above 
ligands and amino acid residues of the CB1 
receptor are shown in Figures 6-8. The data 
obtained show that the main amino acid residues 
forming the binding pocket and causing 
interactions with the ligands at the orthosteric 
binding site in the CB1 active conformation are 
Phe10, Phe72, Ser75, Phe76, Phe79, Phe91, 
Leu95, Val98, Thr99, Phe102, Ile169, Phe170, 
Trp181, Met265, Lys278, Phe281, Ala282, 
Ser285, Cys288. 
 
Figure 6. Ligand interactions of XLR-11 in CB1 active 
conformation. 
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Figure 7. Ligand interactions of PB-22 in CB1 active 
conformation. 
 
 
Figure 8. Ligand interactions of 5F-PB-22 in CB1 active 
conformation. 
 
Thus, the main interactions between the 
studied agonists and the receptor are 
hydrophobic and pi-stacking. All considered 
agonists, except THC, contain N-pentylindole 
fragment in their structures. In this way, the 
pentyl group and aromatic fragments are mainly 
responsible for hydrophobic interactions with 
the receptor, and the indole fragment is 
responsible for pi-stacking interactions. It 
should be noted that either the pyrrole core (in 
XLR-11, Figures 3,6) or the benzene core (in 
5F-PB-22, Figures 5,8), or both indole 
condensed rings simultaneously (in PB-22, 
Figures 4,7), can participate in stacking 
interactions.  
Sometimes hydrophilic interactions also 
occur. For example, the ester group in PB-22 is 
in close proximity to polar amino acid residues 
such as Thr99, Lys278 and Ser285 (Figures 
4,7). Interestingly, for the fluorinated analogue 
of this agonist, 5F-PB-22, such interactions are 
already absent (Figures 5,8). This fact can be 
explained by the different arrangement of the 
pentyl (in PB-22) and fluoropentyl (in 5F-PB-
22) tails in the binding pocket, and, as a result, 
the spatial closure of the 5F-PB-22 ester group.  
Next, we carried out the comparative 
analysis for the studied agonists affinity 
parameters to CB1 receptor and for their 
binding energies calculated via molecular 
docking. The dissociation constant of the 
ligand-receptor complex (Ki) and the half 
maximal effective concentration (EC50) were 
chosen as affinity parameters. High-affinity 
ligand binding implies that a relatively low 
concentration of a ligand is adequate to 
maximally occupy a ligand-binding site and 
trigger a physiological response. The lower the 
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Ki is, the more likely there will be a chemical 
reaction between the ligand and the receptor. 
Low-affinity binding (high Ki values) implies 
that a relatively high concentration of a ligand is 
required before the binding site is maximally 
occupied and the maximum physiological 
response to the ligand is achieved. EC50 refers to 
the concentration of ligand, which induces a 
response halfway between the baseline and 
maximum after a specified exposure time. It is 
commonly used as a measure of a drug’s 
potency. A comparison of these two parameters 
with the calculated binding energies of agonists 
with the CB1 receptor (S-score) is given in the 
Table 1. 
 
Table 1. Comparison of CB1 receptor affinity parameters 
and binding energy from docking for the agonists studied 
Agonist Ki  
(nM) 
EC50 
(nM) 
S-score  
(kcal/mol) 
THC 13.7 250 -9.29 
JWH-018 9.5 102 -9.05 
AM-2201 1.0 38 -9.25 
UR-144 29 421 -9.19 
XLR-11 24 98 -9.28 
PB-22 1.5 5.1 -9.41 
5F-PB-22 0.5 2.8 -9.45 
 
The following conclusion can be drawn 
from the obtained results: there is no strict 
correlation between the actual binding 
parameters and the binding energy estimated as 
docking S score. However, the highest affinity 
agonists (PB-22 and 5F-PB-22) also have the 
highest S-scores. In addition, for all N-
pentylindole derivatives studied, one regularity 
is observed: for monofluorinated analogues, the 
S-score is always slightly higher than for 
fluorine-free ligands. Interestingly, this clearly 
coincides with the correlation of affinity 
parameters for the corresponding fluorine-
free/monofluorinated agonist pairs.  
In addition, it is easy to see that the 
S-score values for all the N-pentylindole 
derivatives studied are in the range of 
-9.29±0.25 kcal/mol, where the first value 
corresponds to the S-score for THC. This result 
is consistent with the fact that all of these 
substances, like THC, are proven agonists of the 
cannabinoid receptor CB1. 
 Molecular dynamics results 
 Using MBAR method, as implemented 
in gmx bar utility, free energies of decoupling a 
ligand from protein, ΔG  ecouple protein, and from 
water, ΔG  ecouple water, were computed. Binding 
free energy denoted ΔGbind (BAR) was 
computed as the difference between the stated 
values (Eq. 1). The results for both forcefields 
are collected in Table 2. Due to the 
computational cost of simulations, for 
CHARMM36 force field, only two ligands 
(THC and UR-144) were examined. 
ΔGbind (BAR) = ΔGdecouple water – ΔGdecouple protein (1) 
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Table 2. Comparison of CB1 receptor affinity parameters 
and MBAR binding energy estimate for the agonists 
Ligand ΔGbind (BAR), kcal/mol 
Forcefield OPLS-AA/M CHARMM36 
THC -22.6 ± 1.5 -26.6 ± 1.8 
PB-22 -20.3 ± 1.1  
5F-PB-22 -15.8 ± 1.1  
XLR-11 -15.3  ± 1.4  
UR-144 -15.1 ± 0.9 -19.1 ± 0.8 
AM-2201 -8.1 ± 1.6  
JWH-018 -7.6 ± 1.2  
 
The ΔGbind values computed via 
MMPBSA approach are listed in Table 3. 
 
Table 3. Comparison of CB1 receptor affinity parameters 
and MMPBSA  binding energy estimatie for the agonists 
Ligand ΔGbind (MMPBSA), kcal/mol 
Forcefield OPLS-AA/M CHARMM36 
THC -42.7 ± 3.3 -37,3 ± 2,5 
PB-22 -43.7 ± 2.5 -32.6 ± 2.7 
5F-PB-22 -40.6 ± 2.5 -32.6 ± 2.6 
XLR-11 -40.4 ± 2.7 -33.5 ± 2.7 
UR-144 -40.4 ± 2.1 -33,1 ± 2,5 
AM-2201 -43.3 ± 2.8 -33.8 ± 2.5 
JWH-018 -44.5 ± 2.5 -36.6 ± 2.6 
Surprisingly, among all the 
characteristics computed here, only ΔGbind 
(BAR) considerably varies between the ligands, 
while the others (S-score and ΔGbind 
(MMPBSA)) are almost equal for all of them 
having the spread within the range of 
uncertainty. However, no evident correlation is 
present between ΔGbind (BAR) and experimental 
affinity parameters of ligands (EC50, Ki), as can 
be seen from comparison (Figure 9). The most 
striking case is UR-144 that has the highest 
EC50 and K among the examined set but shows 
moderate ΔGbind (BAR). 
 Turning to another forcefield does not 
improve the correlation. Both the absolute 
values ΔGbind (MMPBSA) of ligands and their 
order differ in the two forcefields studied, while 
the spread is similarly small (~3 kcal/mol 
between the lowest and the highest values) and 
the uncertainty is of close magnitude (~2.6 
kcal/mol). The same situation is observed for 
ΔGbind (BAR), as well. 
 As a result, as it was shown for 
molecular docking before, two MD-based 
methods of computing binding free energy 
tested here appeared to be able just to determine 
that all examined compounds show high affinity 
to CB1 (i.e. are agonists) but failed to accurately 
distinguish between more and less active 
agonists. 
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Figure 9. ln Ki values of the ligands plotted versus their 
ΔGbind (BAR), computed using, OPLS-AA/M forcefield. 
 
 It is difficult to identify the reasons for 
this issue. Likely, it is not a result of forcefield 
choice, because two representatives shown 
similar behavior. The simulation time was 
several ns that should be enough to sample 
orientations of a ligand in such constrained 
space. For ΔGbind (MMPBSA), the uncertainty 
has to decrease one order of magnitude in order 
to make the values for various ligands 
significantly different, and they still will differ 
slightly by magnitude. Yet, for MBAR, this 
duration may still be insufficient. Also, a tighter 
λ schedule may be important for accurate 
estimations. However, fulfilling both options 
will drastically increase computational cost of 
the method making it unsuitable for application 
to large sets of ligands of interest. 
 A possible source of systematic error is 
the exclusion of water molecules from the 
cavity. A presence of a single water molecule 
may lead to large energy shift in ligand binding 
energy if formation of a hydrogen bond occurs. 
Examining this option requires search for a 
place a water molecule may reside near the 
ligand. Also, it will not affect the ΔGbind 
(MMPBSA) values because in these 
computations, all water is treated implicitly. 
Conclusions 
Extensive computational estimation of 
affinity of a set of agonists to CB1 receptor by 
three different methods was done. However, no 
correlation between the calculated binding free 
energy and experimentally measured affinity 
parameters (EC50, Ki) was observed. As a result, 
the problem of robust discrimination of small 
organic molecules with respect to affinity to 
CB1 receptor by means of computational 
methods remains open. It will be the subject for 
our following investigations. 
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